Skip to Content
UW Health SMPH
American Family Children's Hospital
DONATE Donate
SHARE TEXT

Low-grade Astrocytoma

Contact Information

(608) 263-8500
(800) 323-8942

 

Health Information

Astrocytoma (Brain Tumors)

The UW Health Brain Tumor Center in Madison, Wisconsin provides comprehensive treatment for patients with brain tumors. Working in concert with the UW Carbone Cancer Center, our multidisciplinary team sees more than 1,200 brain tumor patients annually with common as well as rare brain cancers.

 

What are low-grade astrocytoma tumors?

 

Low-grade astrocytoma tumors, also called or grade 2 astrocytoma, are gliomas - tumors that develop from the glial cells (called astrocytes) that support nerves.

 

Astrocytoma tumors are classified in one of four grade categories, with grade 1 being the least aggressive and grade 4 the most aggressive. Low-grade astrocytoma tumors have the potential to invade surrounding tissue but tend to grow slowly. The fall into one of three categories:

  • Fibrillary
  • Protoplasmic
  • Gemistocytic

Symptoms

 

General symptoms include:

  • Headaches
  • Weakness on one side of the body
  • Problems with balance
  • Seizures
  • Behavior, memory and personality changes

Low-grade Astrocytoma Treatment

 

Treatment can vary according to tumor size, location and how far the tumor has spread, but surgery is recommended for tumors that can be removed without causing neurological distress by damaging surrounding tissue.

 

Total tumor removal is the surgical goal, but with surgical removal of low-grade astrocytoma tumors, microscopic tumor cells too small for the neurosurgeon to see are often left behind. Radiation therapy, then, may be recommended after surgery to address any remaining tumor matter or for low-grade astrocytoma tumors for which surgery is not an option.

Tumor Recurrence

 

Low-grade astrocytoma tumors may recur years after initial treatment as grade 3 or grade 4 astrocytoma tumors, which of course necessitates a fresh review of treatment options.

 

Information compiled based on research culled from the American Brain Tumor Association Web site.